ILMN

#588
Illumina Inc
130.09 USD
+2.47%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
130.01
130.60
Year Range
69.88
155.47
Daily Change
+2.47%
Monthly Change
+8.43%
6 month change
+43.57%
Year Change
+73.59%
Previous Close
126.96
Open
130.22
Bid
Ask
Low
130.01
High
130.60
Volume
237
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 19.89 B
  • Employee 8 650
  • Founded 1998
  • CEO Jacob Thaysen
  • Website www.illumina.com
  • Headquarter Delaware, United States
  • FIGI BBG000DSMS70
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
24.68
Price to sales ratio
4.83

Illumina Inc

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries. Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.

News